Type 2 diabetes mellitus, the most frequent subtype of diabetes, is a disease characterized by high levels of blood glucose (hyperglycaemia). It arises from a resistance to and relative deficiency of ...

July 10, 2025 MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 diabetes. The device contains a powdered form of glucagon and ...

A new guideline from WHO conditionally recommends the use of GLP-1s to treat obesity as well as including the drugs as part of a comprehensive obesity treatment framework.